SCHADE CHRISTIAN S 4
4 · Aprea Therapeutics, Inc. · Filed Jun 7, 2022
Insider Transaction Report
Form 4
SCHADE CHRISTIAN S
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2022-06-03$0.81/sh−65,770$52,945→ 226,846 total
Holdings
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 5,000(indirect: By Spouse)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
Footnotes (2)
- [F1]Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 180,934 restricted stock units.
- [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose.